• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    F

    Fukuoka Children's Hospital and Medical Center for Infectious Diseases

    EST. 1980
    715论文总数
    1.2万引用总数

    论文量&引用量时间轴

    机构学者

    论文(715)

    年份
    起
    –
    止
    排序
    1JCS 2026 Guideline on the Management of Infective Endocarditis
    Chisato Izumi,Masao Daimon,Shuichiro Kaji,Akiko Masumoto,Kyomi Ashihara,Masashi Amano,Shiro Uemura,Hideki Ota,Takahiro Ohara,Kenji Okada, Takayuki Kawamura, Masahiko Goya,
    2026Circulation journal official journal of the Japanese Circulation Society(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Re-evaluating Age-Related Attention-Deficit/hyperactivity Disorder (ADHD) Symptom Trajectories Using the Japanese ADHD Rating Scale-5.
    Ryotaro Shimomura, Yukie Tateno, Keisuke Oyatani, Kotaro Nanba,Eri Shiraishi,Masaru Tateno

    Aim:Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention (IA), hyperactivity, and impulsivity. In 2022, the Japanese version of the ADHD Rating Scale-5 (ADHD-RS-5) was released based on DSM-5. Although there are several changes compared to the previous version, few clinical studies have been conducted using the ADHD-RS-5. This study aimed to re-evaluate ADHD-related characteristics by age group in pediatric psychiatric outpatients, using the ADHD-RS-5 regardless of diagnosis, and compare these findings with previous research. Methods:Participants were all patients aged 5-17 years who visited the Psychiatry Clinic of Tokiwa Hospital or the Tokiwa Child Development Center (Child Psychiatry Clinic) during the study period. Of 503 children, 452 met the inclusion criteria. Primary caregivers completed the ADHD-RS-5. Symptom and functional impairment scores were compared by ADHD diagnosis and age group. In the ADHD group, scores were also compared based on pharmacological treatment. Results:IA and hyperactivity-impulsivity (HI) scores were significantly higher in the ADHD group. Functional impairment scores did not differ significantly in some age groups. HI scores were lower in older age bands, whereas IA scores did not differ significantly across age groups; the cross-sectional patterns are compatible with relative stability of inattentive symptoms but do not establish longitudinal persistence. Pharmacological treatment was not linked to symptom scores but was associated with higher impairment scores. Conclusion:Our findings using the ADHD-RS-5 showed results consistent with previous reports regarding age-specific symptom characteristics of ADHD, while also providing new insights into treatment options for ADHD. Clinicians may consider both symptom severity and functional impact when initiating pharmacotherapy. Given medication approval from age 6 in Japan, accurate assessment and diagnosis remain essential, and the ADHD-RS-5 may support decision-making when interpreted alongside clinical judgment and multi-informant input.

    2026PCN reports psychiatry and clinical neurosciences(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3A 13-Year-old Girl Diagnosed with Exercise-Induced Laryngeal Obstruction Through Continuous Laryngoscopy During Exercise
    Tatsuhito Muta, Tsubasa Matsumoto, Kota Nagasawa,Junichiro Tezuka
    2026Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology(2026)
    引用
    AI阅读
    加入学术空间
    4A Case of Postoperative Obstructive Respiratory Failure Caused by Airway Compression from a Hematoma
    Tadashi Kodani, Shoji Fukuoka,Kenichiro Yamamura
    2026Pediatrics International(2026)
    引用
    AI阅读
    加入学术空间
    5Efficacy, Safety, and Pharmacokinetics of Macitentan in Japanese Pediatric Patients with Pulmonary Arterial Hypertension - Prospective, Multicenter, Open-Label Study -
    Ryo Inuzuka,Taku Ishii, Toru Iwasa, Ken-Ichi Kurosaki,Ayako Kuraoka,Jun Narita,Shinichi Takatsuki, Masayoshi Nakano, Rieko Inagaki, Maki Mihoya, Kim Hyunsoo, Minaka Shibuya,

    Background:Pulmonary arterial hypertension (PAH) is characterized by a progressive increase in pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR), imposing an increased workload on the right ventricle and ultimately leading to right heart failure. Macitentan is a potent dual endothelin receptor antagonist that blocks both endothelin receptor subtypes A and B, and is approved for adult patients with PAH, but evidence in pediatric PAH patients is limited. Methods and Results:This was an open-label, multicenter, Phase III study enrolling Japanese pediatric PAH patients aged ≥3 months to <15 years. A total of 7 patients were enrolled. Efficacy was evaluated by assessing pulmonary hemodynamics after 24 weeks of treatment, and safety was assessed over a 52-week period. The geometric mean fold change in PVR index (PVRI) at Week 24 was 59.43%, which met the prespecified success criterion of ≤81.6% (primary endpoint). Other pulmonary hemodynamic parameters, including mean PAP, mean right atrial pressure, and total pulmonary resistance, also showed improvement. Additionally, at Week 52, functional outcomes such as 6-minute walk test performance and quality-of-life reports, demonstrated a trend toward improvement. Safety findings were favorable, with no unexpected concerns among the 7 treated participants. Most adverse events were mild to moderate in severity, and none were considered related to macitentan. Conclusions:Macitentan showed clinically meaningful reduction in PVRI and improved pulmonary hemodynamics in Japanese pediatric patients with PAH, with a favorable safety profile over 52 weeks of treatment.

    2026Circulation reports(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 715 篇论文

    合作机构(100)

    九州大学合作论文 216
    庆应义塾大学合作论文 40
    National Center For Child Health and Development合作论文 35
    东京大学合作论文 34
    九州大学医院合作论文 34
    横滨市立大学合作论文 31
    京都大学合作论文 28
    新潟大学合作论文 28
    东京女子医科大学合作论文 26
    日本大学合作论文 25

    机构统计